· Venture Capital Tracker · investment-strategies  · 1 min read

Reserv's $125M: AI-Native Claims Handling Attracts Big Capital

Reserv raised $125M in May 2026 to scale its AI-driven claims-handling platform, part of the broader insurtech-meets-AI funding wave.

Reserv’s $125M raise in May 2026 rides the same wave lifting Corgi Insurance: AI rebuilding the unglamorous core of insurance — in Reserv’s case, claims.

The problem this startup is attacking

Claims handling is slow, manual, and costly. Reserv applies AI to automate adjudication and administration, aiming to cut cycle times and expense ratios for insurers.

Why this is a live problem now

  • Claims is the largest operational cost center in insurance.
  • AI can triage, document, and process claims faster than legacy TPAs.
  • Insurers want measurable loss-adjustment-expense reduction.

Competitive map

  • Legacy third-party administrators.
  • Other insurtech claims-automation startups.
  • Carriers building in-house AI claims tools.

Market signal (the number to remember)

  • $125M — a sizable round confirming that AI-native insurance operations (not just distribution) are a fundable category in 2026.

Practical takeaway (operator + investor)

Reserv shows the insurtech revival is operations-deep, not just front-end. Founders should target the highest-cost workflows; investors should look for proof of expense-ratio improvement and carrier adoption.

Sources

  1. PipelineRoad / Crunchbase (Reserv $125M, top 10 rounds): https://pipelineroad.com/news/20260508-top-10-biggest-funding-rounds-this-week-in-ai-and-tech

By Venture Capital Tracker

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.

Frequently Asked Questions

Common questions about this topic

Research the entities in this story

Persistent profiles connect this article to the companies and investors it discusses.

Back to Blog

Recommended next

Browse all research »